Ureaplasma urealyticum risk factors

Jump to navigation Jump to search

Ureaplasma urealyticum Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ureaplasma urealyticum from other Bacteria

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Ureaplasma urealyticum risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ureaplasma urealyticum risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ureaplasma urealyticum risk factors

CDC on Ureaplasma urealyticum risk factors

Ureaplasma urealyticum risk factors in the news

Blogs on Ureaplasma urealyticum risk factors

Directions to Hospitals Treating Rhinitis

Risk calculators and risk factors for Ureaplasma urealyticum risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Risk factors that have been identified for Ureaplasma colonization/infection include factors such as heavy urogenital colonization in adults, multiple sexual partners, immunosuppression, and prematurity in neonates.[1][2][3][4][5][6]

Risk factors

Risk factors for Ureaplasma infection in infants include the following:[1][2][3][4][5][6]

Neonatal factors

Maternal factors

Risk factors for Ureaplasma colonization/infection in adult men and women:[7][8][9][10][11][12]

References

  1. 1.0 1.1
  2. 2.0 2.1
  3. 3.0 3.1
  4. 4.0 4.1
  5. 5.0 5.1 Kikhney J, von Schöning D, Steding I, Schulze J, Petrich A, Hiergeist A; et al. (2017). "Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth?". Clin Microbiol Infect. 23 (2): 119.e1–119.e7. doi:10.1016/j.cmi.2016.10.010. PMID 27756710.
  6. 6.0 6.1 Koucký M, Malíčková K, Cindrová-Davies T, Smíšek J, Vráblíková H, Černý A; et al. (2016). "Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy - Results of a pilot study". J Reprod Immunol. 116: 35–41. doi:10.1016/j.jri.2016.04.285. PMID 27172838.
  7. Benedetto C, Tibaldi C, Marozio L, Marini S, Masuelli G, Pelissetto S; et al. (2004). "Cervicovaginal infections during pregnancy: epidemiological and microbiological aspects". J Matern Fetal Neonatal Med. 16 Suppl 2: 9–12. doi:10.1080/14767050410001727107. PMID 15590426.
  8. George MD, Cardenas AM, Birnbaum BK, Gluckman SJ (2015). "Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis". J Clin Rheumatol. 21 (4): 221–4. doi:10.1097/RHU.0000000000000248. PMID 26010188.

Template:WH Template:WS